 BURBANK, Calif., Sept. 29, 2021 GLOBE NEWSWIRE -- via NewMediaWire Medolife Rx, Inc. Medolife, a global integrated bioceutical company with RD, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. OTCQB: QNTA, announced today that it has completed a bi-annual filing with the Ministry of Environment MOE of the Dominican Republic DR, which detailed the expansion of its scorpion reservation and exceeded the expectations of the regulatory body. The MOE expressed further interest in the Companys flagship product, Escozine, which has recently renewed its registration in the DR as a natural alternative medicine for oncological treatments. 